APPLICATION
ANDA074847
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-23
LATEST ACTION
2000-10-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ETODOLACDiscontinued
ETODOLAC 400MG · TABLET · ORAL
ETODOLACDiscontinued
ETODOLAC 500MG · TABLET · ORAL
Approval history
2000-10-16Manufacturing (CMC) · Supplement 1AP
1999-10-15Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.